nach oben

Erschienen in:

13.11.2023 | ORIGINAL ARTICLE

Expression of CD5 in salivary gland tumors: an ancillary marker for carcinoma showing thymus-like differentiation (CASTLE) of the major salivary gland

verfasst von: Eiichi Sasaki, Hoshino Terada, Naoki Oishi, Akari Iwakoshi, Katsuhiro Masago, Hirokazu Matsushita, Hidetaka Yamamoto, Nobuhiro Hanai, Hisashi Tateyama

Erschienen in: Virchows Archiv | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

Recently, cases of carcinoma showing thymus-like differentiation (CASTLE) occurring in major salivary glands have been identified. To assess the diagnostic value of CD5 immunohistochemistry in distinguishing salivary CASTLE from other types of salivary gland tumors, we evaluated CD5 expression in 109 salivary gland tumors, encompassing 23 different histological types, including salivary CASTLE. In addition, we reviewed 10 previously reported cases of salivary CASTLE. Most salivary CASTLE cases (10/11, 91%) showed strong CD5 expression. In contrast, 104 of 108 (96%) non-salivary CASTLE tumors were negative for CD5, while the remaining four tumors (3.7%), all of which were histologically Warthin tumors, showed focal positivity for CD5 with weak to moderate intensity. In conclusion, the findings in this study support the potential use of CD5 immunohistochemistry for distinguishing salivary CASTLE from other histological types of salivary gland tumors. Aberrant CD5 expression in this tumor may be linked to the tumor microenvironment.

Nur mit Berechtigung zugänglich

Wong EHC, Tetter N, Tzankov A, Muller L (2018) CASTLE tumor of the parotid: first documented case, literature review, and genetic analysis of the cancer. Head Neck 40:E1-e4. https://doi.org/10.1002/hed.24985CrossRefPubMed

Lorenz L, von Rappard J, Arnold W, Mutter N, Schirp U, Scherr A, Jehle AW (2019) Pembrolizumab in a patient with a metastatic CASTLE tumor of the parotid. Front Oncol 9:734. https://doi.org/10.3389/fonc.2019.00734CrossRefPubMedPubMedCentral

Huang P, Huang R, Xiao W, Liu W, He T, Zhu W, Li C (2019) Ectopic thymic carcinoma in parotid gland: a rare case and review of literature. Int J Clin Exp Pathol 12:384–388PubMedPubMedCentral

Ardighieri L, Tomasoni M, Battocchio S, Facchetti F, Maroldi R, Nicolai P, Lombardi D (2021) Carcinoma showing thymus-like differentiation (CASTLE) arising in the sublingual gland. Int J Surg Pathol 29:301–307. https://doi.org/10.1177/1066896920941604CrossRefPubMed

Ishikawa T, Ogawa T, Nakanome A, Yamauchi Y, Usubuchi H, Shiihara M, Yoshida T, Okamura Y, Kinoshita K, Katori Y, Furukawa T (2021) Whole exome sequencing and establishment of an organoid culture of the carcinoma showing thymus-like differentiation (CASTLE) of the parotid gland. Virchows Arch: Int J Pathol 478:1149–1159. https://doi.org/10.1007/s00428-020-02981-8CrossRef

Yamamoto H, Kusafuka K, Nozaki Y, Iwasaki T, Nogami M, Hongo T, Yasumatsu R, Oda Y (2021) Carcinoma showing thymus-like differentiation (CASTLE) of the salivary gland: report of 2 cases of a hitherto under-recognized extrathyroid counterpart. Pathol Res Pract 227:153646. https://doi.org/10.1016/j.prp.2021.153646CrossRefPubMed

Kunc M, Kamieniecki A, Walczak G, Nowicki T, Wasąg B, Mikaszewski B, Stodulski D, Biernat W (2022) Intrasalivary thymic carcinoma: a case report and literature review. Head Neck Pathol 16:857–864. https://doi.org/10.1007/s12105-021-01394-6CrossRefPubMed

Cheng J, Shao S, Li L, Zheng N (2022) Ectopic thymic carcinoma of the parotid gland. Int J Oral Maxillofac Surg 51:1516–1519. https://doi.org/10.1016/j.ijom.2022.02.013CrossRefPubMed

Uchiyama T, Terada C, Tachibana Y, Nishiura H, Takeda M, Fujii T, Kimura T, Tsutsumi M, Ohbayashi C (2023) Carcinoma showing thymus-like differentiation of the parotid gland: the brief report of cytomorphology and review of the literature. Diagn Cytopathol 51:E98-e104. https://doi.org/10.1002/dc.25088CrossRefPubMed

10.

Li J, Xiang R, Li Y, Liao Q, Liu Y (2023) Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis. Virchows Arch: Int J Pathol 482:813–822. https://doi.org/10.1007/s00428-023-03536-3CrossRef

11.

Chu PG, Arber DA, Weiss LM (2003) Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. Am J Clin Pathol 120:64–70. https://doi.org/10.1309/48KC-17WA-U69B-TBXQCrossRefPubMed

12.

Hosaka N, Ohe C, Miyasaka C, Nakano Y, Sakaida N, Uemura Y, Saito Y, Ikehara S, Tsubura A, Takahashi H (2016) The role of CD5 expression in thymic carcinoma: possible mechanism for interaction with CD5+ lymphoid stroma (microenvironment). Histopathology 68:450–455. https://doi.org/10.1111/his.12742CrossRefPubMed

13.

Andreadis D, Epivatianos A, Poulopoulos A, Nomikos A, Papazoglou G, Antoniades D, Barbatis C (2006) Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours. Oral Oncol 42:57–65. https://doi.org/10.1016/j.oraloncology.2005.06.014CrossRefPubMed

14.

Kuo T, Hsueh C (1997) Lymphoepithelioma-like salivary gland carcinoma in Taiwan: a clinicopathological study of nine cases demonstrating a strong association with Epstein-Barr virus. Histopathology 31:75–82. https://doi.org/10.1046/j.1365-2559.1997.5830814.xCrossRefPubMed

15.

Kashima J, Hashimoto T, Yoshida A, Goto Y, Ushiku T, Ohe Y, Watanabe SI, Yatabe Y (2022) Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma. Virchows Arch: Int J Pathol 481:893–901. https://doi.org/10.1007/s00428-022-03437-xCrossRef

16.

Sasaki E, Masago K, Fujita S, Hanai N, Yatabe Y (2020) Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck. J Pathol Clin Res 6:154–159. https://doi.org/10.1002/cjp2.157CrossRefPubMedPubMedCentral

17.

Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, Leiserson MDM, Sethi G, Lu C, Ryan M, Su X, Cherniack AD, Robertson G, Akbani R, Spellman P, Weinstein JN, Hayes DN, Raphael B, Lichtenberg T, Leraas K, Zenklusen JC, Fujimoto J, Scapulatempo-Neto C, Moreira AL, Hwang D, Huang J, Marino M, Korst R, Giaccone G, Gokmen-Polar Y, Badve S, Rajan A, Ströbel P, Girard N, Tsao MS, Marx A, Tsao AS, Loehrer PJ (2018) The integrated genomic landscape of thymic epithelial tumors. Cancer Cell 33:244-258.e10. https://doi.org/10.1016/j.ccell.2018.01.003CrossRefPubMedPubMedCentral

Titel: Expression of CD5 in salivary gland tumors: an ancillary marker for carcinoma showing thymus-like differentiation (CASTLE) of the major salivary gland
verfasst von: Eiichi Sasaki
Hoshino Terada
Naoki Oishi
Akari Iwakoshi
Katsuhiro Masago
Hirokazu Matsushita
Hidetaka Yamamoto
Nobuhiro Hanai
Hisashi Tateyama
Publikationsdatum: 13.11.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Virchows Archiv / Ausgabe 6/2024
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-023-03701-8

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Open Access
Original Article

Biphasic synovial sarcoma with myoepithelial features: a distinctive variant with a predilection for the foot

ORIGINAL ARTICLE

Deep learning model to differentiate Crohn’s disease from intestinal tuberculosis using histopathological whole slide images from intestinal specimens

Original Article

Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma

Open Access
ORIGINAL ARTICLE

Comparison of the 7th and revised 8th UICC editions (2020) for oral squamous cell carcinoma: How does the reclassification impact staging and survival?

Open Access
ORIGINAL ARTICLE

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

Open Access
ORIGINAL ARTICLE

Neu im Fachgebiet Pathologie

„KI“ in der Rechtsmedizin – von der Forschung in die Praxis: Welche Herausforderungen ergeben sich?

Open Access
Künstliche Intelligenz
Originalie

Der Einsatz künstlicher Intelligenz (KI) in der Rechtsmedizin ist absehbar, KI-Anwendungen könnten im Ermittlungsverfahren oder in foro bald eine zentrale Rolle in Entscheidungsprozessen einnehmen. Dann werden insbesondere Transparenz …

Latent spaces of generative models for forensic age estimation

Open Access
Original reports

Similar to other parts of our society, machine learning has emerged as a popular tool within different areas of forensic medicine and will soon fuel more and more research and practice niches of our disciplines. Given the rapid advances, the …

Artificial intelligence in forensic pathology: an Australian and New Zealand perspective

Open Access
Leitthema

Artificial intelligence application has gained popularity in the last decade. Its application is implemented into multiple industries including the health sector; however, discipline-specific artificial intelligence applications are not widely …

Künstliche Intelligenz in der forensisch-radiologischen Altersdiagnostik

Künstliche Intelligenz
Leitthema

Fragen zu Implementierung und Nutzbarkeit von künstlicher Intelligenz (KI) spielen eine immer größere Rolle in der Forensischen Altersdiagnostik bei Lebenden, insbesondere im Rahmen forensisch-radiologischer Ansätze. Bis dato liegen bereits …

Springer Medizin

Expression of CD5 in salivary gland tumors: an ancillary marker for carcinoma showing thymus-like differentiation (CASTLE) of the major salivary gland

Abstract

Weitere Artikel der Ausgabe 6/2024

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Biphasic synovial sarcoma with myoepithelial features: a distinctive variant with a predilection for the foot

Deep learning model to differentiate Crohn’s disease from intestinal tuberculosis using histopathological whole slide images from intestinal specimens

Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma

Comparison of the 7th and revised 8th UICC editions (2020) for oral squamous cell carcinoma: How does the reclassification impact staging and survival?

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

Neu im Fachgebiet Pathologie

„KI“ in der Rechtsmedizin – von der Forschung in die Praxis: Welche Herausforderungen ergeben sich?

Latent spaces of generative models for forensic age estimation

Artificial intelligence in forensic pathology: an Australian and New Zealand perspective

Künstliche Intelligenz in der forensisch-radiologischen Altersdiagnostik

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten